AKAM vs NXL · P/E 27, rev $2.17B vs rev $301.6K
Akamai Technologies Inc (AKAM) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. NXL currently screens at market cap $8.5M.
Not investment advice. Open the AKAM and NXL stock pages for the full models.
Not investment advice.